Our study strongly suggests that an impairment of the GH – IGF-I axis appears to be another possible feature of the trisomy 9p syndrome, and these patients should be tested for GH secretion, particularly patients with trisomy 9p syndrome with growth delay and midline cerebral malformations. The gene discussed is TGM2; the disease is Down syndrome.